Rather, the results identify HECs, including LSECs, as key mediators of IFNα-dependent anti-tumor activities that involve the impairment of CRC trans-sinusoidal migration and the development of long-term anti-tumor CD8+ T cell immunity. The gene discussed is IFNA1; the disease is neoplasm.